Overview

Ophthalmic Drugs Market is poised to register a CAGR of 6.4% during the forecast period 2022 to 2028.

Ophthalmic medications are formulations used to treat eye illnesses such as cataract, glaucoma, colour blindness, diabetic macular edoema, cytomegalovirus (CMV) retinitis, and age-related macular degeneration (AMD). The rise in the elderly population, the prevalence of eye diseases such as glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in research and development activities by various healthcare companies are the key factors driving the growth of the global ophthalmic drugs market.

The growth in ophthalmic drug demand, greater healthcare awareness to lower the risk of eye problems, and government initiatives to study and create new combinations of ophthalmic pharmaceuticals are also driving the market. The retinal disease segment dominated the global ophthalmic drugs market by type of indication and is expected to maintain this trend during the forecast period, owing to the rise in the geriatric population, the prevalence of macular degeneration, and the surge in sales of ophthalmic drugs for the treatment of retinal disease. However, the glaucoma segment is expected to grow significantly throughout the forecast period due to rising glaucoma prevalence, rising demand for ophthalmic medications, and increased awareness of glaucoma prevention and treatment.

North America accounted for a significant portion of the global market for ophthalmic drugs and is expected to maintain its leadership during the forecast period due to the rising prevalence of the elderly population, the rise in the prevalence of eye disease, and government initiatives for eye health.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ophthalmic Drugs Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ophthalmic Drugs Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Ophthalmic Drugs Market:
• Aerie Pharmaceuticals, Inc.
• Allergan
• Valeant Pharmaceuticals International, Inc.
• Bayer AG
• Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• Actavis Generics (Teva Pharmaceutical Industries Ltd.)
(Note: The list of the major players will be updated with the latest market scenario and trends)

Ophthalmic Drugs Market Segmentation:
By Product Type
• Prescription Drugs
• OTC Drugs
By Therapeutic Class
• Anti-inflammatory Drugs
   o NSAIDs
   o Steroids
• Anti-infective Drugs
   o Anti-fungal Drugs
   o Anti-bacterial Drugs
   o Others
• Anti-glaucoma Drugs
   o Alpha Agonist
   o Beta Blockers
   o Prostaglandin Analogs
   o Combined Medication
   o Others
• Anti-allergy Drugs
   o Anti-VEGF Agents
   o Others
By Disease Indication
• Dry Eye
• Glaucoma
• Infection/ Inflammation
• Retinal Disorders
  o Wet AMD
  o Dry AMD
  o Diabetic Retinopathy
  o Others
• Allergy
• Uveitis
• Others
By Distribution Channel
• Hospital Pharmacies
• Online Pharmacies
• Independent Pharmacies & Drug Stores
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Ophthalmic Drugs Market By Product Type, By Therapeutic Class, By Disease Indication, Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics